Oklo (OKLO) Could Be 70% Undervalued On Groves 1 Reactor Approval

Groves-1 approval puts Oklo’s test reactor at center stage

The U.S. Department of Energy’s clearance of the Groves-1 test reactor for unrestricted operations has put Oklo (OKLO) back in focus for investors watching early commercial nuclear efforts.

The green light changes Groves-1 from a construction project into an active hub for research, equipment trials, and operator training. Data from these activities is expected to inform Oklo’s planned Aurora powerhouses and isotope facilities.

Oklo’s latest Groves-1 milestone landed in the middle of a volatile stretch, with the share price falling 5.45% on the day, surging 27.34% over the past week, yet still down 68.57% year to date as long term total shareholder returns remain positive on a 3 and 5 year view.

Scan how Oklo compares to other nuclear and grid players by reviewing a curated 17 nuclear energy infrastructure stocks with similar long-cycle infrastructure stories and capital needs.

Oklo now trades at a steep discount to published analyst targets after the Groves-1 rally, while losses widen and contracts remain thin. Is this caution mispriced or a fair reflection of the risk load investors face?

Most Popular Oklo Narrative: 70% Undervalued

On the narrative view, Oklo’s fair value of $80.55 sits far above the last close at $24.45. This frames Groves-1 as one step within a much bigger long term story according to CE, an investor in the Simply Wall St Community who wrote the narrative.

Oklo is another modular / small nuclear reactor maker, calling them Aurora Powerhouses. But it is not trying to sell reactors, it is trying to sell long-term electricity contracts, maintaining ownership of the plants. We’re talking recurring, predictable revenue yo. Not just selling equipment. Obviously, AI data centers are at play here. That’s a big tailwind. 

See why 64 investors see Oklo as 70% undervalued.

Result: Fair Value of $80.55 (UNDERVALUED)

However, Oklo still carries clear pressure points, including widening losses on minimal revenue and the risk that licensing or project timelines may slip further.

Find out about the key risks to this Oklo narrative.

Next Steps

This mix of optimism and concern around Oklo only matters if you act on it. Pressure test the data yourself and see whether the trade-off fits your risk tolerance by weighing the 1 key reward and 6 important warning signs.

Looking for more Oklo-sized ideas?

Do not stop your research with Oklo. Broaden your opportunity set with focused stock lists that surface different types of potential setups in minutes.

• Target future upside potential by scanning a curated pool of quality stocks trading below intrinsic estimates through the 32 high quality undervalued stocks.
• Build a steadier income stream by reviewing companies in the 6 dividend fortresses that pair higher yields with an emphasis on durability.
• Dial down portfolio risk by focusing on the 29 resilient stocks with low risk scores, where financial strength and lower volatility scores take priority over hype.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com